Devlin Jodi
- SEC CIK
- 0001992151
In the past year, 1 open-market sale filing worth $13.2K and no purchases.
Current role at each company
- TLSI TriSalus Life Sciences, Inc.Chief of Clinical Operationsas of Mar 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.2K
- 1 filing
- Net
- −$13.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Devlin Jodi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 (view filing) | Mar 11-16 | 9 daysLate | Devlin JodiChief of Clinical Operations | SSale | −3.21K | $4.11 | −$13.2K | −3.2%97.4K after | 3 lots |
| May 21, 2025 (view filing) | May 19 | 2 days | Devlin JodiChief of Clinical Operations | SSale | −4.76K | $5.18 | −$24.7K | −8.3%52.8K after |